 Firstpost | Wockhardt gets USFDA nod for tablets to check heart attack Business Standard Drug firm Wockhardt today said it has received American health regulator's approval to market clopidogrel bisulfate tablets used for reducing risk of heart attack, in the US market. The company has received final approval from the US Food and Drug ... Wockhardt receives USFDA approval on heart-attack drug Wockhardt to launch generic version of clot-buster drug Plavix Wockhardt receives US FDA approval for Clopidogrel bisulfate tablets |
